Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3

[1]  Carsten Carlberg,et al.  Vitamin D and evolution: pharmacologic implications. , 2020, Biochemical pharmacology.

[2]  F. Hussain,et al.  VD3 mitigates breast cancer aggressiveness by targeting V-H+-ATPase. , 2019, The Journal of nutritional biochemistry.

[3]  D. Goltzman,et al.  Vitamin D-regulated osteocytic sclerostin and BMP2 modulate uremic extraskeletal calcification. , 2019, JCI insight.

[4]  Qingsong Wang,et al.  Vitamin D attenuates lipopolysaccharide-induced inflammatory response in endothelial cells through inhibition of PI3K/Akt/NF-κB signaling pathway. , 2019, Die Pharmazie.

[5]  D. Skrajnowska,et al.  Potential Molecular Mechanisms of the Anti-cancer Activity of Vitamin D , 2019, AntiCancer Research.

[6]  P. Newsholme,et al.  Mechanisms of vitamin D action in skeletal muscle , 2019, Nutrition research reviews.

[7]  M. Suyama,et al.  CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors , 2019, Cancer medicine.

[8]  J. Moan,et al.  High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer , 2019, BMC Cancer.

[9]  G. Luo,et al.  Apolipoprotein M could inhibit growth and metastasis of SMMC7721 cells via vitamin D receptor signaling , 2019, Cancer management and research.

[10]  M. Urashima,et al.  Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial , 2019, JAMA.

[11]  R. Tayyem,et al.  Nutrient intake patterns and breast cancer risk among Jordanian women: a case-control study , 2019, Epidemiology and health.

[12]  B. Carleton,et al.  A comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4.03 ototoxicity grading scales applied to 3,799 audiograms of childhood cancer patients treated with platinum-based chemotherapy , 2019, PloS one.

[13]  Yizuo Song,et al.  Efficacy of neoadjuvant platinum-based chemotherapy during the second and third trimester of pregnancy in women with cervical cancer: an updated systematic review and meta-analysis , 2018, Drug design, development and therapy.

[14]  Yaping Tang,et al.  1,25-dihydroxyvitamin-D3 promotes neutrophil apoptosis in periodontitis with type 2 diabetes mellitus patients via the p38/MAPK pathway , 2018, Medicine.

[15]  K. Hu,et al.  High-performance gene expression and knockout tools using sleeping beauty transposon system , 2018, Mobile DNA.

[16]  P. Hardwidge,et al.  SseL Deubiquitinates RPS3 to Inhibit Its Nuclear Translocation , 2018, Pathogens.

[17]  M. Srinivasan,et al.  Mechanisms of NF-κB p65 and strategies for therapeutic manipulation , 2018, Journal of inflammation research.

[18]  X. Ni,et al.  Up-regulated lipocalin-2 in pediatric thyroid cancer correlated with poor clinical characteristics , 2018, European Archives of Oto-Rhino-Laryngology.

[19]  K. Bumm,et al.  Vitamin D deficiency in head and neck cancer patients – prevalence, prognostic value and impact on immune function , 2018, Oncoimmunology.

[20]  H. Peh,et al.  Ribosomal Protein S3 Gene Silencing Protects Against Cigarette Smoke-Induced Acute Lung Injury , 2018, Molecular therapy. Nucleic acids.

[21]  Gezhi Xu,et al.  Lipocalin 2 Suppresses Ocular Inflammation by Inhibiting the Activation of NF-κβ Pathway in Endotoxin-Induced Uveitis , 2018, Cellular Physiology and Biochemistry.

[22]  J. Mao,et al.  miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer , 2018, Oncogene.

[23]  Y. Liu,et al.  Vitamin intake and pancreatic cancer risk reduction , 2018, Medicine.

[24]  M. Ma,et al.  Stromal expression of JNK1 and VDR is associated with the prognosis of esophageal squamous cell carcinoma , 2018, Clinical and Translational Oncology.

[25]  M. Falasca,et al.  Molecular and cellular mechanisms of chemoresistance in pancreatic cancer. , 2017, Advances in biological regulation.

[26]  M. Boroujerdi,et al.  Calcitriol Reverses Induced Expression of Efflux Proteins and Potentiates Cytotoxic Activity of Gemcitabine in Capan-2 Pancreatic Cancer Cells. , 2017, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[27]  D. Goodlett,et al.  DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian Cancer , 2017, Scientific Reports.

[28]  Viviane de Oliveira Freitas Lione,et al.  NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates. , 2017, Anti-cancer agents in medicinal chemistry.

[29]  James Paul,et al.  Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer , 2016, Clinical Cancer Research.

[30]  H. Kashima,et al.  Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells , 2016, PloS one.

[31]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[32]  Zixian Huang,et al.  1,25-Dihydroxyvitamin D3 alleviates salivary adenoid cystic carcinoma progression by suppressing GPX1 expression through the NF-κB pathway. , 2016, International journal of oncology.

[33]  Emma L. Smith,et al.  The Regulation of NF-κB Subunits by Phosphorylation , 2016, Cells.

[34]  R. Bostick.  Effects of supplemental vitamin D and calcium on normal colon tissue and circulating biomarkers of risk for colorectal neoplasms , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[35]  Andrea Hodgson,et al.  Metalloprotease NleC Suppresses Host NF-κB/Inflammatory Responses by Cleaving p65 and Interfering with the p65/RPS3 Interaction , 2015, PLoS pathogens.

[36]  Jing-jing Han,et al.  Downregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinoma. , 2015, Oncology reports.

[37]  Zhiquan Huang,et al.  High GPX1 expression promotes esophageal squamous cell carcinoma invasion, migration, proliferation and cisplatin-resistance but can be reduced by vitamin D. , 2014, International journal of clinical and experimental medicine.

[38]  E. Vokes,et al.  Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  Inder M. Verma,et al.  NF-κB, an Active Player in Human Cancers , 2014, Cancer Immunology Research.

[40]  H. Bergler,et al.  Ribosomal protein S3 interacts with the NF‐κB inhibitor IκBα , 2014, FEBS letters.

[41]  W. Guo,et al.  Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  Shao-Cong Sun.  The noncanonical NF‐κB pathway , 2012, Immunological reviews.

[43]  S. Baylin,et al.  Double Strand Breaks Can Initiate Gene Silencing and SIRT1-Dependent Onset of DNA Methylation in an Exogenous Promoter CpG Island , 2008, PLoS genetics.

[44]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[45]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[46]  D. Greenwood,et al.  Meta-analysis of Observational Studies , 2012 .

[47]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.